Exploring Human Genetic Variation – Scientific and Ethical Challenges

Author(s):  
Paula Dobosz ◽  
Jakub Zawiła-Niedźwiecki

Since the genomic era is a reality nowadays, we need deeper understanding and consideration upon the benefits and challenges it brings. Apart from all the enthusiasm, there are also concerns related to genomics, specifically to the use and storage of personal genetic information as well as concerns regarding, for instance, so-called incidental findings, and right not to know. It started with Mendel’s simple experiments, but led to high-throughput sequencing technologies, resulting complex genomic data is constantly poured into public and private databases, inevitably changing our current knowledge. With the advent of new techniques and methods, like CRISPR/Cas9 engineering, researchers are provided with improved and expanded repertoire of research tools to analyse an organism in health and disease. This paper is aimed at providing examples of the applications and challenges, both practical and theoretical, in exploring human genetic variation.

Author(s):  
Gülendam Bozdayı ◽  
Işıl Fidan

The viral component of the human microbiome is referred as ‘virobiota’. The virobiota is the sum of all viruses found in or on humans. The set of all genes of virobiota is referred as ‘virome’. The human virome consists of virus-derived genetic elements found in human genome constituted of viruses that infect eukaryotic cells, bacteriophages, prokaryotic cells, and, endogenous retroviruses. The development of new sequencing technologies, such as high-throughput sequencing techniques allowed the analysis of the human virome. Many new viruses have been discovered lately, using new generation sequencing technology. In recent years, there has been an increase in the studies of the human virome as changes in virome have been observed in diseases. The alterations in the human virome may be associated with infectious, inflammatory diseases, cancer and autoimmunity. The understanding of how the virome affects human health and disease can provide the development of potential therapeutic approaches that target the members of the virome.


2017 ◽  
Vol 38 (1) ◽  
pp. 28 ◽  
Author(s):  
Kristin Mühldorfer

Bats are ancient and among the most diverse mammals in terms of species richness, diet and habitat preferences, characteristics that may contribute to a high diversity of infectious agents. During the past two decades, the interest in bats and their microorganisms largely increased because of their role as reservoir hosts or carriers of important pathogens. Rapid advances in microbial detection and characterisation by high-throughput sequencing technologies have led to large genetic data sets but also improved our possibilities and speed of identifying unknown infectious agents. Assessing the risk of infectious diseases in bats and their pathological manifestation, however, is still challenging because of limited access to appropriate material and field data, and continuing limitations in wildlife diagnostics and the interpretation of genetic results. As a consequence, emerging pathogens can suddenly appear with devastating effects as happened for the white nose syndrome. To date, much research on bats and infectious agents still focusses on viruses, whilst the knowledge on bacteria and their role in disease is comparatively low.


Quaternary ◽  
2021 ◽  
Vol 4 (1) ◽  
pp. 6
Author(s):  
Eric Capo ◽  
Charline Giguet-Covex ◽  
Alexandra Rouillard ◽  
Kevin Nota ◽  
Peter D. Heintzman ◽  
...  

The use of lake sedimentary DNA to track the long-term changes in both terrestrial and aquatic biota is a rapidly advancing field in paleoecological research. Although largely applied nowadays, knowledge gaps remain in this field and there is therefore still research to be conducted to ensure the reliability of the sedimentary DNA signal. Building on the most recent literature and seven original case studies, we synthesize the state-of-the-art analytical procedures for effective sampling, extraction, amplification, quantification and/or generation of DNA inventories from sedimentary ancient DNA (sedaDNA) via high-throughput sequencing technologies. We provide recommendations based on current knowledge and best practises.


Blood ◽  
2013 ◽  
Vol 122 (19) ◽  
pp. 3268-3275 ◽  
Author(s):  
Jill M. Johnsen ◽  
Deborah A. Nickerson ◽  
Alex P. Reiner

Abstract Genomic technologies are becoming a routine part of human genetic analysis. The exponential growth in DNA sequencing capability has brought an unprecedented understanding of human genetic variation and the identification of thousands of variants that impact human health. In this review, we describe the different types of DNA variation and provide an overview of existing DNA sequencing technologies and their applications. As genomic technologies and knowledge continue to advance, they will become integral in clinical practice. To accomplish the goal of personalized genomic medicine for patients, close collaborations between researchers and clinicians will be essential to develop and curate deep databases of genetic variation and their associated phenotypes.


2017 ◽  
Vol 45 (3) ◽  
pp. 805-812 ◽  
Author(s):  
Zhi Hao Kwok ◽  
Yvonne Tay

Long noncoding RNAs (lncRNAs) represent one of the largest classes of transcripts and are highly diverse in terms of characteristics and functions. Advances in high-throughput sequencing platforms have enabled the rapid discovery and identification of lncRNAs as key regulatory molecules involved in various cellular processes and their dysregulation in various human diseases. Here, we summarize the current knowledge of the functions and underlying mechanisms of lncRNA activity with a particular focus on cancer biology. We also discuss the potential of lncRNAs as diagnostic and therapeutic targets for clinical applications.


2020 ◽  
Vol 5 ◽  
pp. 119
Author(s):  
Stephanie Johnson ◽  
Michael Parker

Background: Going forward, the routine implementation of genomic surveillance activities and outbreak investigation is to be expected. We sought to systematically identify the emerging ethical challenges; and to systematically assess the gaps in ethical frameworks or thinking and identify where further work is needed to solve practical challenges. Methods: We systematically searched indexed academic literature from PubMed, Google Scholar, and Web of Science from 2000 to April 2019 for peer-reviewed articles that substantively engaged in discussion of ethical issues in the use of pathogen genome sequencing technologies for diagnostic, surveillance and outbreak investigation. Results: 28 articles were identified; nine United States, five United Kingdom, five The Netherlands, three Canada, two Switzerland, one Australia, two South Africa, and one Italy. Eight articles were specifically about the use of sequencing in HIV. Eleven were not specific to a particular disease. Results were organized into four themes: tensions between public and private interests; difficulties with translation from research to clinical and public health practice; the importance of community trust and support; equity and global partnerships; and the importance of context. Conclusion: While pathogen sequencing has the potential to be transformative for public health, there are a number of key ethical issues that must be addressed, particularly around the conditions of use for pathogen sequence data. Ethical standards should be informed by public values, and further empirical work investigating stakeholders’ views are required. Development in the field should also be under-pinned by a strong commitment to values of justice, in particular global health equity.


2014 ◽  
Author(s):  
Gargi Dayama ◽  
Sarah B Emery ◽  
Jeffrey M Kidd ◽  
Ryan E Mills

The transfer of mitochondrial genetic material into the nuclear genomes of eukaryotes is a well-established phenomenon. Many studies over the past decade have utilized reference genome sequences of numerous species to characterize the prevalence and contribution of nuclear mitochondrial insertions to human diseases. The recent advancement of high throughput sequencing technologies has enabled the interrogation of genomic variation at a much finer scale, and now allows for an exploration into the diversity of polymorphic nuclear mitochondrial insertions (NumtS) in human populations. We have developed an approach to discover and genotype previously undiscovered Numt insertions using whole genome, paired-end sequencing data. We have applied this method to almost a thousand individuals in twenty populations from the 1000 Genomes Project and other data sets and identified 138 novel sites of Numt insertions, extending our current knowledge of existing Numt locations in the human genome by almost 20%. Most of the newly identified NumtS were found in less than 1% of the samples we examined, suggesting that they occur infrequently in nature or have been rapidly removed by purifying selection. We find that recent Numt insertions are derived from throughout the mitochondrial genome, including the D-loop, and have integration biases consistent with previous studies on older, fixed NumtS in the reference genome. We have further determined the complete inserted sequence for a subset of these events to define their age and origin of insertion as well as their potential impact on studies of mitochondrial heteroplasmy.


Sign in / Sign up

Export Citation Format

Share Document